• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Frequency of p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer.

作者信息

Cavagna Rodrigo, Escremim de Paula Flávia, Sant'Anna Débora, Santana Iara, da Silva Vinicius D, da Silva Eduardo C A, Bacchi Carlos E, Miziara José E, Dias Josiane M, De Marchi Pedro, Leal Leticia F, Reis Rui M

机构信息

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.

出版信息

JCO Glob Oncol. 2021 Apr;7:639-645. doi: 10.1200/GO.20.00615.

DOI:10.1200/GO.20.00615
PMID:33956502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8162527/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b6/8162527/04405cc9aedd/go-7-go.20.00615-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b6/8162527/2714f5684a70/go-7-go.20.00615-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b6/8162527/04405cc9aedd/go-7-go.20.00615-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b6/8162527/2714f5684a70/go-7-go.20.00615-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b6/8162527/04405cc9aedd/go-7-go.20.00615-g004.jpg

相似文献

1
Frequency of p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer.巴西肺癌患者中p.Gly12Cys突变的频率
JCO Glob Oncol. 2021 Apr;7:639-645. doi: 10.1200/GO.20.00615.
2
Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.巴西肺腺癌的突变特征揭示了 EGFR 突变与高亚洲裔人群的关联，以及 KRAS 突变具有独立的预后作用。
Sci Rep. 2019 Mar 1;9(1):3209. doi: 10.1038/s41598-019-39965-x.
3
Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.巴西肺癌患者的表皮生长因子受体和 KRAS 突变。
Clinics (Sao Paulo). 2012;67(5):419-24. doi: 10.6061/clinics/2012(05)03.
4
Cancer: Closing the door on KRAS-mutant lung cancer.癌症：为KRAS突变型肺癌关上大门。
Nat Rev Drug Discov. 2016 Nov 3;15(11):747. doi: 10.1038/nrd.2016.216.
5
EGFR and KRAS Mutations in Triple-Mutated Lung Cancer.三突变肺癌中的表皮生长因子受体（EGFR）和 Kirsten 大鼠肉瘤病毒癌基因（KRAS）突变
J Thorac Oncol. 2017 Jul;12(7):e92-e93. doi: 10.1016/j.jtho.2017.02.022.
6
Targeting the KRAS G12C mutation in patients with advanced solid tumors.针对晚期实体瘤患者的KRAS G12C突变
Clin Adv Hematol Oncol. 2019 Nov;17(11):612-614.
7
Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers.用于治疗 KRAS 突变型肺癌的药物联合疗法。
Curr Top Med Chem. 2019;19(23):2128-2142. doi: 10.2174/1568026619666190902150555.
8
KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.非小细胞肺癌和结直肠癌中的 KRAS 突变：对 EGFR 靶向治疗的影响。
Lung Cancer. 2014 Feb;83(2):163-7. doi: 10.1016/j.lungcan.2013.11.010. Epub 2013 Nov 21.
9
Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases.微卫星不稳定性在巴西非小细胞肺癌混合人群中罕见：526例病例队列研究
Pathobiology. 2022;89(2):101-106. doi: 10.1159/000520023. Epub 2021 Nov 15.
10
Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.中国Ib期肺腺癌患者的并发癌基因突变谱
Medicine (Baltimore). 2014 Dec;93(29):e296. doi: 10.1097/MD.0000000000000296.

引用本文的文献

1
Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.基于 RNA 的 nCounter 检测 NTRK 融合可作为一种可行的诊断方法，用于评估非小细胞肺癌的实际情况。
Sci Rep. 2023 Dec 1;13(1):21168. doi: 10.1038/s41598-023-48613-4.
2
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.加拿大共识推荐意见：KRAS G12C 突变型 NSCLC 的管理
Curr Oncol. 2023 Jul 6;30(7):6473-6496. doi: 10.3390/curroncol30070476.
3
Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in Mutant Non-Small Cell Lung Cancer Cell Lines.

本文引用的文献

1
Distribution of Somatic Mutations across Race, Sex, and Cancer Type.体细胞突变在种族、性别和癌症类型中的分布。
N Engl J Med. 2021 Jan 14;384(2):185-187. doi: 10.1056/NEJMc2030638.
2
Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).巴西非小细胞肺癌患者的全面基因组分析（GBOT 0118/LACOG0418）。
Thorac Cancer. 2021 Mar;12(5):580-587. doi: 10.1111/1759-7714.13777. Epub 2020 Dec 13.
3
KRAS Inhibition with Sotorasib in Advanced Solid Tumors.索托拉西布治疗晚期实体瘤的 KRAS 抑制作用。
依维莫司联合第二代泛表皮生长因子受体抑制剂在突变型非小细胞肺癌细胞系中的疗效。
Int J Mol Sci. 2022 Jul 14;23(14):7774. doi: 10.3390/ijms23147774.
4
Daily Practice Assessment of Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner.非小细胞肺癌患者病情的日常实践评估：胸科病理学家面临的一项新挑战即将来临。
Cancers (Basel). 2022 Mar 23;14(7):1628. doi: 10.3390/cancers14071628.
5
Comprehensive Analysis of a Nine-Gene Signature Related to Tumor Microenvironment in Lung Adenocarcinoma.肺腺癌中与肿瘤微环境相关的九基因特征的综合分析
Front Cell Dev Biol. 2021 Sep 1;9:700607. doi: 10.3389/fcell.2021.700607. eCollection 2021.
N Engl J Med. 2020 Sep 24;383(13):1207-1217. doi: 10.1056/NEJMoa1917239. Epub 2020 Sep 20.
4
Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.巴西患者肺腺癌的突变图谱：临床分子谱分析的过去、现在与未来
Front Oncol. 2020 Jul 2;10:1068. doi: 10.3389/fonc.2020.01068. eCollection 2020.
5
RAS-targeted therapies: is the undruggable drugged?RAS 靶向治疗：无药可治的靶点被攻克了？
Nat Rev Drug Discov. 2020 Aug;19(8):533-552. doi: 10.1038/s41573-020-0068-6. Epub 2020 Jun 11.
6
Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup.GNAS、TP53 和 PTEN 的表达改善了 Sonic Hedgehog（SHH）髓母细胞瘤亚组患者的预后。
J Mol Diagn. 2020 Jul;22(7):957-966. doi: 10.1016/j.jmoldx.2020.04.207. Epub 2020 May 4.
7
Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas.巴西恶性胸膜间皮瘤中驱动肿瘤抑制和癌基因的突变分析。
Pathobiology. 2020;87(3):208-216. doi: 10.1159/000507373. Epub 2020 May 5.
8
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.临床 KRAS(G12C) 抑制剂 AMG 510 可引发抗肿瘤免疫。
Nature. 2019 Nov;575(7781):217-223. doi: 10.1038/s41586-019-1694-1. Epub 2019 Oct 30.
9
Genotyping and Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.希腊非小细胞肺癌患者的基因分型和突变：发生率、意义及对治疗的影响。
Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):531-541. doi: 10.21873/cgp.20155.
10
Analysis of Predictive Biomarkers in Patients With Lung Adenocarcinoma From Southern Brazil Reveals a Distinct Profile From Other Regions of the Country.巴西南部肺腺癌患者预测生物标志物分析显示与该国其他地区不同的特征。
J Glob Oncol. 2019 Sep;5:1-9. doi: 10.1200/JGO.19.00174.